View in EDS HTML Full Text PDF Full Text

Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.

Saved in:
Bibliographic Details
Title: Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
Authors: Busnadiego, Idoia1 (AUTHOR), Abela, Irene A.1,2 (AUTHOR), Frey, Pascal M.2,3 (AUTHOR), Hofmaenner, Daniel A.4 (AUTHOR), Scheier, Thomas C.2 (AUTHOR), Schuepbach, Reto A.4 (AUTHOR), Buehler, Philipp K.4 (AUTHOR), Brugger, Silvio D.2 (AUTHOR) silvio.brugger@usz.ch, Hale, Benjamin G.1 (AUTHOR) silvio.brugger@usz.ch
Source: PLoS Biology. 7/5/2022, Vol. 20 Issue 7, p1-16. 16p. 3 Charts, 3 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15449173
DOI:10.1371/journal.pbio.3001709